Biomarkers for diagnosing alzheimer's disease

Details Biomarkers for diagnosing alzheimer's disease Biomarkers for diagnosing alzheimer's disease

G - Physics

01

N

G01N 33/53 (2006.01) G01N 33/483 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2745998

A method for assessing the state of Alzheimer's disease in patients is disclosed. A method for monitoring the progression of Alzheimer's disease in patients is also disclosed. The method applies detection of specific markers in body fluids (e.g. CSF), using mass spectrometric analysis (SELDI-TOF MS). The specific markers are: human cystatin C, human beta-2-microglobulin, human myoglobin neurosecretory protein VGF or fragments of these proteins.

Affiliated with

Also associated with

Rating

Biomarkers for diagnosing alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biomarkers for diagnosing alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for diagnosing alzheimer's disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1718800